| # | Drug | Count |
|---|---|---|
| 0 | NICOTINE POLACRILEX | 618 |
| 1 | LENALIDOMIDE | 526 |
| 2 | DEXAMETHASONE | 507 |
| 3 | DEXAMETHASONE 1.5 MG | 505 |
| 4 | ASPIRIN | 414 |
| 5 | ASPIRIN 325 MG | 395 |
| 6 | ASPIRIN 81 MG | 395 |
| 7 | NICOTINE | 329 |
| 8 | OMEPRAZOLE MAGNESIUM | 290 |
| 9 | FUROSEMIDE | 258 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CALAMINE | 18 | 0.0405 |
| 1 | FERRIC OXIDE RED | 18 | 0.0399 |
| 2 | NICOTINE POLACRILEX | 618 | 0.0161 |
| 3 | CHROMIC CHLORIDE | 11 | 0.0128 |
| 4 | SODIUM THIOSULFATE | 7 | 0.0125 |
| 5 | ZOLBETUXIMAB | 16 | 0.0105 |
| 6 | PALONOSETRON HYDROCHLORIDE | 48 | 0.0089 |
| 7 | HYALURONATE SODIUM | 13 | 0.0085 |
| 8 | CHLORPROMAZINE | 52 | 0.0083 |
| 9 | APREPITANT | 62 | 0.0082 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 886 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 729 |
| 2 | Cholinergic Nicotinic Agonist [EPC] | 649 |
| 3 | Thalidomide Analog [EPC] | 620 |
| 4 | GLP-1 Receptor Agonist [EPC] | 575 |
| 5 | Platinum-based Drug [EPC] | 467 |
| 6 | Benzodiazepine [EPC] | 443 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 439 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 421 |
| 9 | Proton Pump Inhibitor [EPC] | 409 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 135 | 0.0155 |
| 1 | Adrenocorticotropic Hormone [EPC] | 12 | 0.0134 |
| 2 | Cholinergic Nicotinic Agonist [EPC] | 649 | 0.0106 |
| 3 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 16 | 0.0105 |
| 4 | Provitamin D2 Compound [EPC] | 190 | 0.0064 |
| 5 | Endoglycosidase [EPC] | 11 | 0.0059 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 34 | 0.0058 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 12 | 0.0058 |
| 8 | Antidiarrheal [EPC] | 1 | 0.0042 |
| 9 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 5 | 0.0040 |